Related Experiment Videos
Clinical pharmacological studies with 6-azidomorphine
Drug and Alcohol Dependence
|June 1, 1976
Summary
6-deoxy-6-dihydroazido-isomorphine (6-AM) demonstrated significant analgesic effects with less respiratory and circulatory depression than morphine. Side effects like nausea and vomiting were also less frequent and severe compared to morphine.
Area of Science:
- Pharmacology
- Pain Management
- Clinical Trials
Background:
- Opioid analgesics, such as morphine, are effective for pain relief but are associated with significant side effects, including respiratory and circulatory depression.
- Novel opioid analogs are being investigated to identify compounds with improved safety profiles and comparable efficacy.
- 6-deoxy-6-dihydroazido-isomorphine (6-AM) is a synthetic opioid derivative with potential analgesic properties.
Purpose of the Study:
- To evaluate the safety and efficacy of 6-deoxy-6-dihydroazido-isomorphine (6-AM) in healthy human volunteers.
- To compare the circulatory and respiratory effects of 6-AM with those of morphine.
- To assess the analgesic properties and side effect profile of 6-AM administered via intravenous and intramuscular routes.
Main Methods:
- A dose-ranging study involving intravenous (i.v.) and intramuscular (i.m.) administration of 6-AM (4 mug/kg) to healthy adult male volunteers.
- Assessment of circulatory and respiratory parameters, including blood pressure, heart rate, and respiratory rate.
- Evaluation of analgesic efficacy using various experimental pain models (ischemic, electrical stimulation, tooth pulp).
- Monitoring and recording of adverse events, including nausea, vomiting, euphoria, lightheadedness, and myosis.
Main Results:
- Intravenous 6-AM caused minimal circulatory and transient respiratory depression.
- Intramuscular 6-AM exhibited significant analgesic effects, particularly against ischemic and severe pain.
- Compared to equianalgesic doses of morphine, 6-AM demonstrated less circulatory and respiratory depression.
- Side effects such as nausea and vomiting were less frequent and severe with 6-AM than with morphine.
Conclusions:
- 6-deoxy-6-dihydroazido-isomorphine (6-AM) possesses considerable analgesic potential with a more favorable safety profile regarding cardiorespiratory depression compared to morphine.
- The side effect profile of 6-AM, including nausea and vomiting, appears to be less pronounced than that of morphine.
- Further research into 6-AM as a potential analgesic agent is warranted, considering its improved safety and efficacy.